PCN70 ECONOMIC EVALUATION ON THE USE OF PLERIXAFOR ALONGSIDE THE GRANULOCYTE-COLONY STIMULATING FACTOR (GCSF) IN PREPARATION FOR AN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION ON PATIENTS WITH NON HODGKINS LYMPHOMA
Abstract
Authors
G Salinas J Idrovo L Zapata